MeiraGTx Holdings (MGTX) Common Equity (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Common Equity came in at -$5.8 million in Q4 2025, down 108.54% YoY from $67.8 million in Q4 2024, and up 85.72% on a QoQ basis from -$40.6 million in Q3 2025.
MeiraGTx Holdings (MGTX) Common Equity (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Common Equity data on file, last reported at -$5.8 million in Q4 2025.
- Quarterly Common Equity fell 108.54% year-over-year to -$5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.8 million (down 108.54% YoY) and the FY2025 annual result came in at -$5.8 million, down 108.54% from the prior year.
- Common Equity advanced to -$5.8 million in Q4 2025, from -$40.6 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $220.8 million in Q1 2021 to a low of -$40.6 million in Q3 2025.
- A 5-year average of $107.1 million and a median of $119.7 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity surged 34.93% — and 2025, when it slumped 142.36%.
- Tracing MGTX's Common Equity over 5 years: stood at $185.4 million in 2021, then sank by 36.5% to $117.7 million in 2022, then rose by 17.36% to $138.2 million in 2023, then tumbled by 50.91% to $67.8 million in 2024, then sank by 108.54% to -$5.8 million in 2025.
- The last three Common Equity figures came in at -$5.8 million (Q4 2025), -$40.6 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | -5.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -40.56 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Mar 31, 2025 | 33.10 Mn |
| Dec 31, 2024 | 67.83 Mn |
| Sep 30, 2024 | 95.74 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 121.73 Mn |
| Dec 31, 2023 | 138.18 Mn |
| Sep 30, 2023 | 91.89 Mn |
| Jun 30, 2023 | 123.53 Mn |
| Mar 31, 2023 | 90.22 Mn |
| Dec 31, 2022 | 117.74 Mn |
| Sep 30, 2022 | 122.67 Mn |
| Jun 30, 2022 | 141.97 Mn |
| Mar 31, 2022 | 161.29 Mn |
| Dec 31, 2021 | 185.40 Mn |
| Sep 30, 2021 | 187.84 Mn |
| Jun 30, 2021 | 205.72 Mn |
| Mar 31, 2021 | 220.79 Mn |